In Search of Analgesia: Emerging Roles of GPCRs in Pain

Overview

Journal Mol Interv

Specialty Molecular Biology

Date 2009 Oct 16

PMID 19828831

Citations 32

Authors

Laura S Stone

Derek C Molliver

Affiliations

Soon will be listed here.

Abstract

Of all clinically marketed drugs, greater than thirty percent are modulators of G protein-coupled receptors (GPCRs). Nearly 400 GPCRs (i.e., excluding odorant and light receptors) are encoded within the human genome, but only a small fraction of these seven-transmembrane proteins have been identified as drug targets. Chronic pain affects more than one-third of the population, representing a substantial societal burden in use of health care resources and lost productivity. Furthermore, currently available treatments are often inadequate, underscoring the significant need for better therapeutic strategies. The expansion of the identified human GPCR repertoire, coupled with recent insights into the function and structure of GPCRs, offers new opportunities for the development of novel analgesic therapeutics.

Citing Articles

Phylogenetic Analysis Provides Insight Into the Molecular Evolution of Nociception and Pain-Related Proteins.

Zhai R, Wang Q Evol Bioinform Online. 2023; 19:11769343231216914.

PMID: 38107163 PMC: 10725132. DOI: 10.1177/11769343231216914.

Excitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain.

Breitinger U, Breitinger H Mol Med. 2023; 29(1):53.

PMID: 37069517 PMC: 10111846. DOI: 10.1186/s10020-023-00647-0.

Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice.

Bernard A, Danigo A, Mroue M, Rovini A, Richard L, Nizou A Pharmaceutics. 2022; 14(12).

PMID: 36559317 PMC: 9788598. DOI: 10.3390/pharmaceutics14122823.

The Role of G Protein-Coupled Receptor Kinase 6 Regulation in Inflammation and Pain.

Stegen M, Frey U Int J Mol Sci. 2022; 23(24).

PMID: 36555521 PMC: 9784940. DOI: 10.3390/ijms232415880.

Exploring pharmacological inhibition of G as an analgesic strategy.

Marwari S, Kowalski C, Martemyanov K Br J Pharmacol. 2022; 179(23):5196-5208.

PMID: 35900909 PMC: 9633401. DOI: 10.1111/bph.15935.

References

Hurley R, Adams M . Sex, gender, and pain: an overview of a complex field. Anesth Analg. 2008; 107(1):309-17. PMC: 2715547. DOI: 10.1213/01.ane.0b013e31816ba437. View

Hokfelt T, Brumovsky P, Shi T, Pedrazzini T, Villar M . NPY and pain as seen from the histochemical side. Peptides. 2007; 28(2):365-72. DOI: 10.1016/j.peptides.2006.07.024. View

Prado G, Taylor L, Zhou X, Ricupero D, Mierke D, Polgar P . Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol. 2002; 193(3):275-86. DOI: 10.1002/jcp.10175. View

Kaneko S, Mori A, Tamura S, Satoh M, Takagi H . Intracerebroventricular administration of angiotensin II attenuates morphine-induced analgesia in mice. Neuropharmacology. 1985; 24(11):1131-4. DOI: 10.1016/0028-3908(85)90204-7. View

Brown D, Sihra T . Presynaptic signaling by heterotrimeric G-proteins. Handb Exp Pharmacol. 2007; (184):207-60. DOI: 10.1007/978-3-540-74805-2_8. View

Authier F, Desbuquois B . Glucagon receptors. Cell Mol Life Sci. 2008; 65(12):1880-99. PMC: 11131795. DOI: 10.1007/s00018-008-7479-6. View

Foord S, Bonner T, Neubig R, Rosser E, Pin J, Davenport A . International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev. 2005; 57(2):279-88. DOI: 10.1124/pr.57.2.5. View

Neugebauer V . Metabotropic glutamate receptors--important modulators of nociception and pain behavior. Pain. 2002; 98(1-2):1-8. DOI: 10.1016/s0304-3959(02)00140-9. View

Traub R, Tang B, Ji Y, Pandya S, Yfantis H, Sun Y . A rat model of chronic postinflammatory visceral pain induced by deoxycholic acid. Gastroenterology. 2008; 135(6):2075-83. PMC: 2782449. DOI: 10.1053/j.gastro.2008.08.051. View

10.

Carlton S, Zhou S, Du J, Hargett G, Ji G, Coggeshall R . Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel. Pain. 2004; 110(3):616-627. DOI: 10.1016/j.pain.2004.04.042. View

11.

Nagae M, Hiraga T, Wakabayashi H, Wang L, Iwata K, Yoneda T . Osteoclasts play a part in pain due to the inflammation adjacent to bone. Bone. 2006; 39(5):1107-1115. DOI: 10.1016/j.bone.2006.04.033. View

12.

Tepper S, Stillman M . Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine. Headache. 2008; 48(8):1259-68. DOI: 10.1111/j.1526-4610.2008.01214.x. View

13.

Khodorova A, Navarro B, Jouaville L, Murphy J, Rice F, Mazurkiewicz J . Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat Med. 2003; 9(8):1055-61. DOI: 10.1038/nm885. View

14.

Kelly M, Beuckmann C, Williams S, Sinton C, Motoike T, Richardson J . Neuropeptide B-deficient mice demonstrate hyperalgesia in response to inflammatory pain. Proc Natl Acad Sci U S A. 2005; 102(28):9942-7. PMC: 1174999. DOI: 10.1073/pnas.0503795102. View

15.

Khasar S, Lin Y, Martin A, Dadgar J, McMahon T, Wang D . A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron. 2000; 24(1):253-60. PMC: 11587340. DOI: 10.1016/s0896-6273(00)80837-5. View

16.

Oertel B, Lotsch J . Genetic mutations that prevent pain: implications for future pain medication. Pharmacogenomics. 2008; 9(2):179-94. DOI: 10.2217/14622416.9.2.179. View

17.

Patapoutian A, Tate S, Woolf C . Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov. 2009; 8(1):55-68. PMC: 2755576. DOI: 10.1038/nrd2757. View

18.

Luyten F, Tylzanowski P, Lories R . Wnt signaling and osteoarthritis. Bone. 2009; 44(4):522-7. DOI: 10.1016/j.bone.2008.12.006. View

19.

Sanders R, Brian D, Maze M . G-protein-coupled receptors. Handb Exp Pharmacol. 2008; (182):93-117. DOI: 10.1007/978-3-540-74806-9_5. View

20.

Gomes I, Jordan B, Gupta A, Trapaidze N, Nagy V, Devi L . Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J Neurosci. 2000; 20(22):RC110. PMC: 3125672. View